Clinical Trial Update: Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two doses of MG01CI to placebo in adults with ADHD (predominantly inattentive type) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• MG01CI

Snippet

Sponsor: Alcobra Ltd. | Conditions: ADHD Predominantly Inattentive Type | Phase 2 | Status: COMPLETED